Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Greening India’s MSMEs: A Roadmap for Clean Industrial Transition
- 2 Renewables as an Employment Engine: India’s Opportunities and Risks
- 3 Global Water Bankruptcy: Living Beyond Our Hydrological Means
- 4 Robust Groundwater Governance: Anchoring India’s Water Security
- 5 Citizen-Centric Healthcare: Pathway to Universal Health Coverage in India
- 6 Reshaping India’s Juvenile Justice Framework
- 7 Biomaterials: Leveraging Eco-friendly Alternatives for a Low-Carbon Economy
- 8 Strategic Autonomy and the UN Charter: Navigating the Venezuela and Greenland Crises
- 9 India-EU Free Trade Agreement: A Strategic Bet on Trade, Talent and Supply Chains
- 10 Urban Wastewater Management: A Crisis and a Call for Reform

